Live feed
Filing
SCHEDULE 13D/A
SCHEDULE 13D/A0001213900-26-009785·AEON Biopharma, Inc.
Schedule 13D ownership disclosure
AEON Biopharma, Inc.
Common Stock, $0.0001 par value per share · CUSIP: 00775E102
Event date: 2025-03-24
Reporting persons may disclose overlapping interests. Their amounts are shown individually and are not added into a filing total.
- Filing-level shares
- Unavailable
- Percent of class
- Unavailable
- Daewoong Co.,Ltd. ("DWC")Reported CIK 0001985493
Shares: 91,357.00 · Class: 0.9%
- Daewoong Pharmaceutical Co. Ltd ("DWP")
Shares: 33,334.00 · Class: 0.3%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001213900-26-009785
- Form type
- SCHEDULE 13D/A
- Filer
- AEON Biopharma, Inc.
- CIK
- CIK 1837607
- Filed
- Jan 29, 2026
- Reporting period
- Mar 24, 2025
- Description
- Schedule 13D beneficial ownership